CarDS Lab At ACC 2025

The CarDS Lab is thrilled to be be represented by 15 lab members in 28 sessions at ACC 2025 in Chicago!

The CarDS Lab is excited to be at ACC 2025 with 15 members in 28 sessions! Join us in Chicago as we share our latest in AI-driven cardiovascular care, including—

  • Young Investigator Award finalist Arya Aminorroaya, MD, MPH on Tirzepatide for T2DM management

  • AI for cardiac diagnosis using ECG and Echo to detect disease and assess risk

  • Digital biomarkers for CVD prediction and personalized disease progression

  • Precision inference to optimize treatment strategies from clinical trials

  • Digital health policy insights through wearable health data sharing in cardiovascular care

  • NLP in EHRs for scalable phenotyping and medication cost evaluation

See you there! #ACC25

Previous
Previous

New Pub: AI–Enabled Prediction of HF Risk From Single-Lead ECGs

Next
Next

CarDS Lab welcomes its newest member, Dr. Bruno Batinica